ExodusPoint Capital Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-281,795
| Closed | -$826K | – | 1328 |
|
|
2024
Q4 | $826K | Buy |
+281,795
| New | +$826K | 0.01% | 914 |
|
|
2024
Q2 | – | Sell |
-496,012
| Closed | -$2.25M | – | 1326 |
|
|
2024
Q1 | $2.25M | Buy |
496,012
+362,358
| +271% | +$1.64M | 0.02% | 552 |
|
|
2023
Q4 | $763K | Buy |
+133,654
| New | +$763K | 0.01% | 841 |
|
|
2023
Q3 | – | Sell |
-214,557
| Closed | -$1.39M | – | 1586 |
|
|
2023
Q2 | $1.39M | Sell |
214,557
-37,635
| -15% | -$243K | 0.01% | 889 |
|
|
2023
Q1 | $1.9M | Buy |
252,192
+71,842
| +40% | +$542K | 0.02% | 812 |
|
|
2022
Q4 | $1.83M | Buy |
180,350
+5,600
| +3% | +$56.7K | 0.03% | 664 |
|
|
2022
Q3 | $1.73M | Sell |
174,750
-87,753
| -33% | -$868K | 0.02% | 833 |
|
|
2022
Q2 | $2.8M | Buy |
262,503
+133,652
| +104% | +$1.42M | 0.03% | 606 |
|
|
2022
Q1 | $1.26M | Buy |
128,851
+46,026
| +56% | +$449K | 0.02% | 963 |
|
|
2021
Q4 | $1.18M | Buy |
+82,825
| New | +$1.18M | 0.01% | 948 |
|
|
2021
Q3 | – | Sell |
-29,972
| Closed | -$659K | – | 1976 |
|
|
2021
Q2 | $659K | Buy |
29,972
+20,729
| +224% | +$456K | 0.01% | 1148 |
|
|
2021
Q1 | $314K | Sell |
9,243
-19,607
| -68% | -$666K | ﹤0.01% | 1589 |
|
|
2020
Q4 | $1.16M | Buy |
+28,850
| New | +$1.16M | 0.01% | 723 |
|